Must Read News Articles – September 11

ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 10th August. Click Here for more information.




India and neighbors

Dhaka plea made MEA shift stand: (The Hindu)

Delhi broke silence on Rohingya issue.

The disaster next door: (The Hindu, Editorial)

India’s stance on the Rohingya refugees undermines its ties with Bangladesh and its regional leadership.

Shifting ties: (Indian Express, Editorial)

Despite Look East talk, Delhi’s reflexes have been much slower than Beijing. For India and Myanmar, a challenging road ahead.

Indian Constitution

Refugees go to SC against Article 35A: (The Hindu)

They migrated from West Pakistan.


Indian Economy. Planning, Growth and Employment

Fall in GDP figures structural, not transient, says SBI report: (The Hindu)

‘Govt. must not cut spending as growth drivers are missing’.

‘NPAs: challenge is to avoid delays’: (The Hindu)

Bankers worry that appeals to other courts and the workload at NCLT may push deadlines out further.

GST: efficiencies have risen in manufacturing: (The Hindu)

India’s manufacturing sector gives a major thrust to economic growth, contributing to the GDP, creating employment opportunities and attracting foreign investments.

Search for quality: (The Hindu, Editorial)

SEBI’s proposed rules may not necessarily improve the quality of credit rating services.

Pollution and conservation

A forest policy on today’s terms:  (The Hindu, Editorial)

The National Forest Policy must be refreshed as it contains concepts that have been long discarded.

Cropping pattern, Agriculture, e-technology

No feel for the pulse: (Indian Express, Editorial)

Prices crashed last year because there was a glut in imports during a year of record production. Government has not corrected the policy snags that led to this anomaly.

Prelims Related News

Why infections picked up in hospitals are the big threat today, how world is trying to cope:

CARB-X, or Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, is a public-private international partnership, which was set up in 2016 to focus on innovations to improve diagnosis and treatment of drug-resistant infections.

India, U.S. in talks for C-17 deal: (The Hindu)

The aircraft will be handed over within a month of signing the contract.


Print Friendly and PDF